United Therapeutics (UTHR) insider Rothblatt files to sell 199,500 shares after option exercise
Rhea-AI Filing Summary
United Therapeutics (UTHR) insider Martine Rothblatt, through Morgan Stanley Smith Barney LLC Executive Financial Services, filed to sell 199,500 shares of common stock under Form 144. The proposed sale, related to an exercise of stock options on 08/03/2026, reflects an aggregate market value of $103,283,145.00, with prior sales over the past three months made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 199,500 shares
Aggregate market value: $103,283,145.00
Shares per recent 10b5-1 sale: 9,500 shares
+3 more
6 metrics
Shares to be sold
199,500 shares
Common stock covered by the Form 144 notice
Aggregate market value
$103,283,145.00
Value associated with 199,500 shares in the Form 144
Shares per recent 10b5-1 sale
9,500 shares
Typical size of each Rule 10b5-1 sale from 05/04/2026–07/31/2026
Example 10b5-1 sale amount
$5,600,468.50
Dollar amount for a 9,500-share sale on 05/06/2026
Shares outstanding reference
42,446,733 shares
Shares outstanding figure referenced alongside Form 144 data
Option exercise date
08/03/2026
Date tied to the exercise of stock options for the proposed sale
Key Terms
Form 144, Rule 10b5-1, Exercise of Stock Options, aggregate market value
4 terms
Form 144 regulatory
"144: Securities Information Common | Morgan Stanley Smith Barney LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 10b5-1 regulatory
"10b5-1 Sales for MARTINE ROTHBLATT 1000 SPRING ST"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"Common | 08/03/2026 | Exercise of Stock Options | Issuer"
aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services 1"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 144 filing by UTHR insider Martine Rothblatt disclose?
The filing discloses a planned sale of 199,500 shares of United Therapeutics common stock, with an aggregate market value of $103,283,145.00, following an exercise of stock options dated 08/03/2026.
Are the UTHR stock sales by Martine Rothblatt under a Rule 10b5-1 plan?
Yes. The filing lists multiple sales as 10b5-1 Sales for Martine Rothblatt, indicating they were executed under a pre-arranged Rule 10b5-1 trading plan during May–July 2026, each typically for 9,500 shares of common stock.
Who is the broker named in the United Therapeutics (UTHR) Form 144?
The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This firm is identified in connection with the 199,500-share proposed sale of UTHR common stock.